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Effects of the COVID-19 pandemic on maternal and perinatal 
outcomes: a systematic review and meta-analysis
Barbara Chmielewska, Imogen Barratt, Rosemary Townsend, Erkan Kalafat, Jan van der Meulen, Ipek Gurol-Urganci, Pat O’Brien, Edward Morris, 
Tim Draycott, Shakila Thangaratinam, Kirsty Le Doare, Shamez Ladhani, Peter von Dadelszen, Laura Magee, Asma Khalil
Summary
Background The COVID-19 pandemic has had a profound impact on health-care systems and potentially on pregnancy 
outcomes, but no systematic synthesis of evidence of this effect has been undertaken. We aimed to assess the collective 
evidence on the effects on maternal, fetal, and neonatal outcomes of the pandemic.
Methods We did a systematic review and meta-analysis of studies on the effects of the pandemic on maternal, fetal, 
and neonatal outcomes. We searched MEDLINE and Embase in accordance with PRISMA guidelines, from 
Jan 1, 2020, to Jan 8, 2021, for case-control studies, cohort studies, and brief reports comparing maternal and perinatal 
mortality, maternal morbidity, pregnancy complications, and intrapartum and neonatal outcomes before and during 
the pandemic. We also planned to record any additional maternal and offspring outcomes identified. Studies of solely 
SARS-CoV-2-infected pregnant individuals, as well as case reports, studies without comparison groups, narrative or 
systematic literature reviews, preprints, and studies reporting on overlapping populations were excluded. Quantitative 
meta-analysis was done for an outcome when more than one study presented relevant data. Random-effects estimate 
of the pooled odds ratio (OR) of each outcome were generated with use of the Mantel-Haenszel method. This review 
was registered with PROSPERO (CRD42020211753).
Findings The search identified 3592 citations, of which 40 studies were included. We identified significant increases 
in stillbirth (pooled OR 1·28 [95% CI 1·07–1·54]; I²=63%; 12 studies, 168 295 pregnancies during and 198 993 before 
the pandemic) and maternal death (1·37 [1·22–1·53; I²=0%, two studies [both from low-income and middle-
income countries], 1 237 018 and 2 224 859 pregnancies) during versus before the pandemic. Preterm births before 
37 weeks’ gestation were not significantly changed overall (0·94 [0·87–1·02]; I²=75%; 15 studies, 170 640 and 
656 423 pregnancies) but were decreased in high-income countries (0·91 [0·84–0·99]; I²=63%; 12 studies, 
159 987 and 635 118 pregnancies), where spontaneous preterm birth was also decreased (0·81 [0·67–0·97]; two 
studies, 4204 and 6818 pregnancies). Mean Edinburgh Postnatal Depression Scale scores were higher, indicating 
poorer mental health, during versus before the pandemic (pooled mean difference 0·42 [95% CI 0·02–0·81; three 
studies, 2330 and 6517 pregnancies). Surgically managed ectopic pregnancies were increased during the pandemic 
(OR 5·81 [2·16–15·6]; I²=26%; three studies, 37 and 272 pregnancies). No overall significant effects were identified 
for other outcomes included in the quantitative analysis: maternal gestational diabetes; hypertensive disorders of 
pregnancy; preterm birth before 34 weeks’, 32 weeks’, or 28 weeks’ gestation; iatrogenic preterm birth; labour 
induction; modes of delivery (spontaneous vaginal delivery, caesarean section, or instrumental delivery); post-
partum haemorrhage; neonatal death; low birthweight (<2500 g); neonatal intensive care unit admission; or Apgar 
score less than 7 at 5 min.
Interpretation Global maternal and fetal outcomes have worsened during the COVID-19 pandemic, with an increase 
in maternal deaths, stillbirth, ruptured ectopic pregnancies, and maternal depression. Some outcomes show 
considerable disparity between high-resource and low-resource settings. There is an urgent need to prioritise safe, 
accessible, and equitable maternity care within the strategic response to this pandemic and in future health crises.
Funding None.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
The SARS-CoV-2 pandemic has had profound effects on 
health-care systems, societal structures, and the world 
economy.1 The adverse effects of the COVID-19 pandemic 
on maternal and perinatal health are not limited to the 
morbidity and mortality caused directly by the disease 
itself. Nationwide lockdowns, disruption of health-care 
services, and fear of attending health-care facilities might 
also have affected the wellbeing of pregnant people and 
their babies.2,3
Emerging evidence suggests that rates of stillbirth and 
preterm birth might have changed substantially during 
the pandemic.4,5 A reduction in health-care-seeking 
behaviour, as well as reduced provision of maternity 
services, has been suggested as a possible cause.6 Robust 
estimates of the indirect maternal health effects of the 
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akhalil@sgul.ac.uk pandemic can be derived from historical cohorts by 
examining the change in outcomes and calculating the 
excess event rate.7 This before–after approach applied to 
key pregnancy outcomes can be used to estimate the 
indirect effects of the COVID-19 pandemic.
We aimed to assess the collateral effects on maternal, 




We did a systematic review and meta-analysis of studies 
on the effects of the pandemic on maternal, fetal, 
and neonatal outcomes. The review was registered with 
PROSPERO (CRD42020211753) and reported according 
to PRISMA guidelines.8 The study protocol is available 
online.
Search strategy, selection criteria, and data extraction
We electronically searched the MEDLINE and Embase 
databases from Jan 1, 2020, to Jan 8, 2021. The search 
included relevant medical subject heading terms, 
keywords, and word variants for stillbirth, perinatal 
mortality, maternal mortality and morbidity, preterm 
birth, obstetric complications, mode of delivery, and 
COVID-19 (appendix p 4). No language restrictions were 
applied. One article, which was subsequently excluded, 
was translated from Mandarin.
Abstracts and potentially relevant full texts were 
reviewed independently by three authors (BC, IB, and RT) 
with any conflicts resolved by consensus. Case-control 
studies, cohort studies, and brief reports were eligible 
for inclusion. Case reports, studies without comparison 
groups, narrative or systematic literature reviews, preprint 
papers, and studies reporting on overlapping populations 
were excluded. Studies of only SARS-CoV-2-infected 
women were excluded.
Data were extracted with use of Covidence systematic 
review software (version 2, Veritas Health Innovation, 
Melbourne, VIC, Australia). The following data were 
extracted: author’s name, publication date, study design, 
sampling period, study period, study population, and 
location. The total number of pregnant women and the 
sum of adverse events in each group were extracted for 
categorical outcomes (eg, stıllbirth, caesarean section). 
Mean, standard deviation, and the total number of 
pregnant women in each outcome group were extracted 
for outcomes reported on a continuous scale (Edinburgh 
Postnatal Depression Scale [EPDS] scores). 
Outcomes of interest included maternal and perinatal 
mortality, maternal morbidity, pregnancy complications, 
and intrapartum and neonatal outcomes. We planned to 
record any additional maternal and offspring outcomes 
identified. Where papers described service configuration 
or resource-use changes without clinical outcomes, we 
excluded them from the analysis.
Pandemic mitigation response measures were extracted 
from the Oxford COVID-19 Government Response 
Tracker.9 We recorded the maximum restrictions imple-
mented during the study timeframe. Quantitative assess-
ment of the severity of mitigation measures was recorded 
according to the Government Response Stringency Index 
(GRSI) developed by the Blavatnik School of Government 
at the University of Oxford (Oxford, UK).9
Quality assessment
Each study was scored according to the Newcastle-
Ottawa Scale10 independently by two assessors (BC, IB) 
Research in context
Evidence before this study
Before conducting this study, we electronically searched 
MEDLINE and Embase from Jan 1, 2020, to Jan 8, 2021, with no 
language restriction, to identify any previous systematic 
reviews and meta-analyses. Search terms included stillbirth, 
perinatal mortality, maternal mortality and morbidity, preterm 
birth, obstetric complications, mode of delivery, and COVID-19. 
Large systematic reviews have consistently reported that 
pregnant individuals infected with SARS-CoV-2 are more likely 
to require intensive care treatment and experience preterm 
birth. Although individual studies have reported pandemic-
associated changes in pregnancy outcomes in the general 
maternity population, particularly for preterm birth and 
stillbirth, no global synthesis of this kind has previously been 
reported.
Added value of this study
This review provides a comprehensive assessment of the global 
effects of the COVID-19 pandemic on maternal, fetal, birth, 
and neonatal outcomes. We identified significant increases in 
maternal and fetal mortality (particularly in low-income and 
middle-income countries [LMICs]), ruptured ectopic 
pregnancies, and maternal symptoms of depression. Moreover, 
we found a reduction in preterm birth in high-income countries 
during the pandemic epoch.
Implications of all the available evidence
The disruption caused by the COVID-19 pandemic has led to 
avoidable deaths of both mothers and babies. Policy makers 
and health-care leaders must urgently investigate robust 
strategies for preserving safe and respectful maternity care, 
even during the ongoing global emergency. Our findings 
highlight a disproportionate impact on LMICs. Immediate 
action is required to avoid rolling back decades of investment in 
reducing mother and infant mortality in low-resource settings. 
There is also an unprecedented opportunity to investigate the 
mechanisms underlying the observed reduction in preterm 
birth and generate novel preventive interventions.
For Covidence software see 
https://www.covidence.org/
See Online for appendix
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on three broad characteristics: selection of study groups, 
comparability of groups, and ascertainment of the 
outcome of interest.
Statistical analysis
Quantitative meta-analysis was done for an outcome 
when more than one study presented relevant data. We 
excluded individual outcomes from studies reporting no 
adverse outcomes in one or both groups, and studies 
not satisfying the normality assumption for continuous 
variables. We divided studies according to World Bank 
classifications into high-income or low-income and 
middle-income contexts.
A random-effects estimate of the pooled odds of each 
outcome was generated with use of the Mantel-Haenszel 
method. Between-study heterogeneity was explored 
using the I² statistic, with substantial heterogeneity 
defined as an I² value greater than 50%. Meta-regression 
analyses were done for outcomes with substantial 
heterogeneity to investigate the relative contribution of 
the WHO Healthcare Efficiency Index11 and the strin-
gency of lockdown measures (quantified with the GRSI).9 
GRSI scores were scaled and regression coefficients 
corresponded to one standard unit change in the 
respective covariate. Positive regression coefficients 
indicate an increase in the effect size whereas negative 
coefficients show a decrease. We reported p values and 
the amount of accounted heterogeneity for each covariate. 
Potential publication bias was assessed with Egger’s test 
and funnel plots for visual inspection when sufficient 
studies (n>10) were available.
Analyses were done with R software (version 4.0.2).
Role of the funding source
There was no funding source for this study.
Results
Of 3592 abstracts screened, 192 were relevant for full-text 
review and 40 met the inclusion criteria for systematic 
review (figure 1).4,5,12–49 A list of excluded studies with 
reasons for exclusion is provided in the appendix (p 6). 
Reporting on resource use or service reconfiguration 
outcomes is summarised in the appendix (p 27). Of the 
40 included studies, 31 for which comparable outcomes 
were also reported in at least one other study were 
included in the meta-analysis.4,12,14–21,24–28,30–34,37,38,40,42,45–49 
Table 1 shows the characteristics of the 40 included 
studies, all of which used a historical cohort design. 
17 countries were represented, with substantial variation 
in pandemic mitigation measures among countries. No 
study reported data from countries in the lowest WHO 
Healthcare Efficiency Index quartile, and the majority 
(28 studies)4,5,12,14,16,17,19,20,22,23,28–37,39,40,42,44–46,48,49 reported data 
from countries in the highest quartile (table 2). 21 of 
the 31 studies included in the quantitative analysis 
were from high-income countries (HICs) according to 
the World Bank classification.4,12,14,16,17,19,20,23,28,30–34,42,45,46,49 The 
reported outcomes and outcome measures are listed 
with the relevant studies in the appendix (p 31).
The majority of the included studies were of moderate 
methodological rigour (ie, 6–8 stars on the Newcastle-
Ottawa Scale; table 1; appendix p 35). The main 
weaknesses were inconsistent definition and reporting of 
outcomes, inconsistency in selection of control groups, 
and retrospective study design. For example, although 
18 papers4,5,14–17,19–21,26,28,30–33,38,47,49 reported on preterm birth, 
variation in the gestational age cutoffs and use of ranges 
limited their comparability.
There were five reports from national registries,5,17,27,37,47 
six regional reports,28,37,41,43–45 and four multicentre 
studies;16,21,25,46 the remaining 25 were single-centre studies. 
11 studies12,15,19,23,24,33,38,39,42,45,49 had a comparison group from 
the equivalent period in 2019, the year preceding the 
pandemic. Nine studies16,17,20,28,30–32,35,47 had a comparison 
group of annually matched periods from several preceding 
years (table 1). 18 studies4,5,13,14,18,21,22,25–27,29,36,37,41,43,44,46,48 had a 
comparison group from immediately before the lock-
down period in the respective country. Exposed sample 
sizes varied from nine to 56 720 pregnancies (table 2). 
Only 19 studies5,14–16,19,21,22,24,26,28,30,33,34,39,41,42,47 adjusted for 
3592 studies identified through database searching 
(MEDLINE, Embase)
2615 studies screened 
192 full-text articles assessed for eligibility 
40 studies included in qualitative synthesis 
31 studies included in quantitative synthesis 
(meta-analysis) 
977 duplicate studies removed
2423 studies excluded 
9 studies with outcomes not reported in 
any other study in the systematic review




2 preprint (published version available)
5 preprint (published version not 
available)
54 no comparison group
7 wrong comparator
9 wrong outcomes
24 wrong outcomes (resource use)
35 wrong study design
Figure 1: PRISMA flow chart
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Country Study 
population






Data collection period Newcastle-
Ottawa 
Scale score
Pandemic group Control group
Ayaz et al, 202022 Turkey Single centre Maternal anxiety and depression 63 NR April 12 to 
May 27, 2020
June 1, 2018, to 
April 11, 2020
6
Been et al, 20205 Netherlands National Preterm birth 56 720 1 599 547 March 9 to 
July 16, 2020
Oct 9, 2010, to 
March 8, 2020
9
Berghella et al, 
202033
USA Single centre Overall preterm birth, spontaneous preterm birth, 
iatrogenic preterm birth, caesarean section, vaginal 
delivery, perinatal death
1197 2108 March 1 to 
July 31, 2020
March 1 to 
July 31, 2019
8





Maternal emotions and concerns 1258 1754 April 2 to 
April 23, 2020
April 1, 2018, to 
March 1, 2020
6
Bhatia et al, 202045 UK Regional 
(northwest 
England)
Caesarean rate 8381 17 424 April 1 to 
July 1, 2020
Similar period in 
2019
7
Bornstein et al, 
202046
USA Multicentre Vaginal delivery, caesarean section 5877 11 770 March 15 to 
June 20, 2020
Dec 8, 2019, to 
March 14, 2020
7





Casadio et al, 202048 Italy Single centre Ectopic pregnancy 9 201 March 1 to 
April 30, 2020
Jan 1, 2014, to 
Feb 29, 2020
7
De Curtis et al, 
202049
Italy Single centre Preterm birth, caesarean section, stillbirth 7755 16 808 March 1 to 
May 31, 2020
March 1 to 
May 31, 2019
6
Dell’Utri et al, 202012 Italy Single centre Ectopic pregnancy, vaginal delivery, induction of 
labour, stillbirth
3647 9291 Feb 23 to 
June 24, 2020
Feb 23 to 
June 24, 2019
7
Goyal et al, 202113 India Single centre Maternal death 633 1749 April 1 to 
Aug 31, 2020
Oct 1, 2019, to 
Feb 29, 2020
8
Greene et al, 202014 USA Single centre Vaginal delivery, caesarean section, instrumental 
delivery, NICU admission, 5-min Apgar score, cord 
blood gas, preterm birth
920 1936 March 1 to 
April 30, 2020
Jan 1 to 
Feb 29, 2020
9
Gu et al, 202015 China Single centre Gestational hypertension, gestational diabetes, 
preterm birth, caesarean section, vaginal delivery, 
stillbirth, 5-min Apgar score, NICU admission, 
maternal anxiety
271 582 Jan 1 to 
Feb 29, 2020
Jan 1 to 
Feb 28, 2019
5
Handley et al, 202116 USA Multicentre Stillbirth, overall preterm birth, spontaneous 
preterm birth, iatrogenic preterm birth





Hedermann et al, 
202117





Hui et al, 202018 Hong Kong Single centre Vaginal delivery, caesarean section, instrumental 
delivery, post-partum depression
954 4531 Jan 5 to 
April 30, 2020
Jan 1, 2019, to 
Jan 4, 2020
5
Justman et al, 202019 Israel Single centre Gestational hypertension, gestational diabetes, 
induction of labour, caesarean section, instrumental 
delivery, preterm birth, 5-min Apgar score, NICU 
admission, stillbirth, post-partum haemorrhage
610 1352 March 1 to 
April 30, 2020
March 1 to 
April 30, 2019
9





Kc et al, 202021 Nepal Multicentre Induction of labour, caesarean section, preterm 
birth, stillbirth, neonatal death
7165 20 354 March 21 to 
May 30, 2020
Jan 1 to 
March 20, 2020
9
Khalil et al, 20204 UK Single centre Gestational hypertension, gestational diabetes, 
stillbirth, preterm birth, caesarean section, NICU 
admission
1718 3399 Feb 1 to 
June 14, 2020
Oct 1, 2019, to 
Jan 31, 2020
7
Kugelman et al, 
202023 
Israel Single centre NICU admission, umbilical cord blood pH, 5-min 
Apgar score
398 942 March 15 to 
April 12, 2020
March 15 to 
April 12, 2019
7
Kumar et al, 202124 India Single centre Stillbirth 3610 9771 March 1 to 
Sept 30, 2020
March 1 to 
Sept 30, 2019
9
Kumari et al, 202025 India Multicentre Caesarean section, maternal death, stillbirth 3527 9736 March 25 to 
June 2, 2020
Jan 15 to 
March 24, 2020
5
(Table 1 continues on next page)
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socioeconomic status, ethnic background, comorbidities, 
or other confounding factors.
A summary of the findings from included studies is 
shown in table 2. Meta-analysis was done for 21 outcomes 
for which more than one study was available for 
quantitative synthesis (table 3).
Three studies13,25,27 included data on maternal death, all of 
which reported an increase during the pandemic compared 
with before the pandemic, although this increase was 
statistically significant in only one study.25 Two studies in 
which statistical analysis was done, from India and Mexico, 
were included in the meta-analysis (1 237 018 pregnancies 
during and 2 224 859 before the pandemic), which showed 
a significant increase in maternal death during the 
pandemic (OR 1·37 [95% CI 1·22–1·53]; I²=0%; table 3, 
figure 2A), with findings dominated by a single study.27
Country Study 
population






Data collection period Newcastle-
Ottawa 
Scale score
Pandemic group Control group
(Continued from previous page)
Li et al, 202026 China Single centre Preterm birth, caesarean section 3432 10 591 Jan 23 to 
March 24, 2020





Mexico National Maternal death, post-partum haemorrhage 523* 7747* Jan 1 to 
Aug 9, 2020
2011–19 7
Main et al, 202028 USA Regional 
(California)







Ireland Single centre Pregnancy-specific stress 235 445 June 16 to 
July 17, 2020
May 1, 2019, to 
Feb 29, 2020
5
McDonnell et al, 
202030
Ireland Single centre Preterm birth, stillbirth, neonatal death, caesarean 
section, instrumental delivery, induction of labour, 
gestational hypertension, post-partum 
haemorrhage





Meyer et al, 202031 Israel Single centre Induction of labour, preterm birth, vaginal delivery, 
instrumental delivery, caesarean section, stillbirth, 
5-min Apgar score, NICU admission





Mor et al, 202032 Israel Single centre Gestational diabetes, gestational hypertension, 
stillbirth, preterm birth, vaginal delivery, caesarean 
section, instrumental delivery, induction of labour, 
birthweight, 5-min Apgar score, umbilical cord 
blood pH, NICU admission





Pariente et al, 202034 Israel Single centre Gestational diabetes, gestational hypertension, 
post-partum depression, maternal depression and 
suicidal ideation
223 346 March 18 to 
April 29, 2020
Nov 1, 2016, to 
April 30, 2017
5





Silverman et al, 
202036
USA Single centre Postpartum depression 155 485 March 12 to 
June 12, 2020
Feb 2 to 
March 11, 2020
6
Stowe et al, 202137 UK National Stillbirth 131 218 270 963 April 1 to 
June 30, 2020
April 1, 2019, to 
June 30, 2020
7
Sun et al, 202038 Brazil Single centre Preterm birth, vaginal delivery, instrumental 
delivery, caesarean section, 5-min Apgar score
40 81 March 11 to 
June 11, 2020
March 11 to 
June 11, 2019
6
Suzuki et al, 202039 Japan Single centre Maternal depression and anxiety 117 251 March 11 to 
April 13, 2020
March 9 to 
April 11, 2019
8





Wu et al, 202041 China Regional 
(ten provinces in 
China)
Postpartum depression, maternal anxiety 1285 4124 Jan 21 to 
Feb 9, 2020
Jan 1 to 
Jan 20, 2020
9
Xie et al, 202143 China Regional 
(Zhejiang)
Maternal depression, maternal anxiety 689 3348 Jan 1 to 
Aug 31, 2020
March 1 to 
Dec 31, 2019
5
Zanardo et al, 202042 Italy Single centre Postpartum depression 91 192 March 8 to 
May 3, 2020
March 8 to 
May 3, 2019
7
NR=not reported. NICU=neonatal intensive care unit. *Maternal deaths.
Table 1: Characteristics of included studies
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Statistically significant increase during 
pandemic
Statistically significant decrease during 
pandemic
Statistically non-significant change
Ayaz et al, 202022 77·78 0·734 Maternal anxiety (IDAS II score), moderate 
and severe maternal anxiety (BAI score)
No maternal anxiety (BAI score), mild 
maternal anxiety (BAI score)
None
Been et al, 20205 79·63 0·928 None Preterm birth before 37 weeks’ 
gestation post mitigation measures 
introduced on March 9
Preterm birth before 37 weeks’ gestation post mitigation 
measures introduced on March 15–23
Berghella et al, 
202033
72·69 0·838 None Overall preterm birth before 37 weeks’ 
gestation, preterm birth before 
34 weeks’ gestation, preterm birth 
before 28 weeks’ gestation
Caesarean section, vaginal delivery, stillbirth, iatrogenic 
preterm birth before 37 weeks’ gestation, spontaneous 
preterm birth before 37 weeks’ gestation
Berthelot et al, 
202044
74·54 0·881 Depressive and anxiety symptoms, 
dissociative symptoms, symptoms of 
post-traumatic stress disorder, negative 
affectivity
Positive affectivity None
Bhatia et al, 202045 79·63 0·925 Caesarean section None None
Bornstein et al, 
202046
72·69 0·838 None None Caesarean section, vaginal delivery
Caniglia et al, 
202047
86·11 0·388 None Preterm birth before 37 weeks’ 
gestation, preterm birth before 
32 weeks’ gestation
Neonatal death, stillbirth
Casadio et al, 
202048
93·52 0·991 Ruptured ectopic pregnancy (needing 
surgical intervention)
None None
De Curtis et al, 
202049
93·52 0·991 Stillbirth Preterm birth before 37 weeks’ 
gestation
Caesarean section
Dell’Utri et al, 
202012
75·46 0·991 Stillbirth, induction of labour None Vaginal delivery, surgical management of ectopic 
pregnancy
Goyal et al, 202113 100·0 0·617 None None Maternal death
Greene et al, 202014 72·69 0·838 None None Vaginal delivery, caesarean section, instrumental 
delivery, NICU admission, 5-min Apgar score <7, 
umbilical cord blood pH 
Gu et al, 202015 81·02 0·485 Gestational hypertension, gestational 
diabetes
None Caesarean section, stillbirth, gestational diabetes, 
vaginal delivery, NICU admission, mean Apgar score
Handley et al, 
202116
72·69 0·838 None None Stillbirth, preterm birth before 37 weeks’ gestation, 
spontaneous preterm birth, iatrogenic preterm birth
Hedermann et al, 
202117
72·22 0·862 Preterm birth before 28 weeks’ gestation None Preterm birth at 28–32 weeks’ gestation, preterm birth 
at 32–36 weeks’ gestation 
Hui et al, 202018 66·67 0·485 Postnatal depression (EPDS score ≥10 
1 day after delivery)
None Vaginal delivery, caesarean section, instrumental 
delivery, postnatal depression (EPDS score)
Justman et al, 
202019 
94·44 0·884 Gestational diabetes, gestational 
hypertension
None Caesarean section, induction of labour, instrumental 
delivery, stillbirth, preterm birth before 37 weeks’ 
gestation and before 32 weeks’ gestation, post-partum 
haemorrhage, 5-min Apgar score <7, umbilical cord 
blood pH, NICU admission
Kasuga et al, 202020 47·22 0·957 None Gestational hypertension, preterm 
birth before 27 weeks’ gestation
Preterm birth (gestation not specified)
Kc et al, 202021 96·3 0·457 Caesarean section, induction of labour, 
stillbirth, neonatal death, preterm birth 
before 37 weeks’ gestation
None Vaginal delivery, birthweight <2·5 kg
Khalil et al, 20204 79·63 0·925 Stillbirth Gestational hypertension Caesarean section, preterm birth before 37 weeks’ 
gestation and before 34 weeks’ gestation, gestational 
diabetes, NICU admission
Kugelman et al, 
202023 
94·44 0·884 None None NICU admission, umbilical cord blood pH <7·1, 5-min 
Apgar score <7
Kumar et al, 202124 100·0 0·617 Stillbirth None None
Kumari et al, 202025 100·0 0·617 Caesarean section, maternal death, 
stillbirth
None None
Li et al, 202026 81·94 0·485 Caesarean section None None
(Table 2 continues on next page)
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14 studies from nine countries provided data on the 
incidence of stillbirth during (168 295 births) and before 
the pandemic (165 118 births).4,12,15,16,19,21,24,25,30–32,37,47,49 Two of 
these studies were excluded (Gu et al15 because no adverse 
outcomes were reported and Khalil et al4 because of 
cohort overlap with another larger study in the analysis37). 
Meta-analysis of the remaining 12 studies found a 
significant increase in the rate of stillbirth (pooled 
OR 1·28 [95% CI 1·07–1·54]; I²=63%; table 3, figure 2B). 
A subgroup analysis according to study setting produced 
similar findings, but only the subgroup of low-income 
and middle-income countries (LMICs) reached statis-
tical significance (1·29 [1·06–1·58]; I²=64%), whereas 
HICs did not (1·38 [0·94–2·02]; I²=52%). Funnel plot 
asym metry testing did not show a significant publication 
bias effect (p=0·12; appendix p 42). One study reported 
on antepartum and intrapartum stillbirth separately and 
found no difference in the proportion of antenatally 
diagnosed stillbirth, despite an overall increase in 
stillbirth in this tertiary centre in India.24 One study 
excluded antepartum stillbirth by definition because only 
women carrying a live fetus at admission were enrolled.21
Three studies reported on neonatal death. The largest, 
from Nepal,21 found a statistically significant increase, 
but two smaller studies30,47 identified no significant 
change. The pooled OR for studies included in the meta-
analysis (detailing 13 214 births during and 22 570 before 










Statistically significant increase during 
pandemic
Statistically significant decrease during 
pandemic
Statistically non-significant change
(Continued from previous page)
Lumbreras-Marquez 
et al, 202027
82·41 0·755 No statistical analysis done No statistical analysis done No statistical analysis done
Main et al, 202028 72·69 0·838 Preterm birth at 28–32 weeks’ gestation None Preterm birth before 28 weeks’ gestation, at 32–37 weeks’ 
gestation, before 37 weeks’ gestation (combined)
Matvienko-Sikar 
et al, 202029
90·74 0·924 None None Pregnancy-specific stress (NuPDQ score)
McDonnell et al, 
202030
90·74 0·924 None None Birthweight <2·5 kg, stillbirth, neonatal death (early and 
late), caesarean section, instrumental delivery (vacuum 
and forceps), vaginal delivery, induction of labour, 
gestational hypertension, pre-eclampsia, post-partum 
haemorrhage, preterm birth before 37 weeks’ gestation, 
preterm birth before 26 weeks’ gestation
Meyer et al, 202031 94·44 0·884 None Preterm birth before 34 weeks’ 
gestation, NICU admission
Induction of labour, preterm birth before 37 weeks’ 
gestation and before 32 weeks’ gestation, vaginal 
delivery, instrumental delivery, caesarean section, 
stillbirth, 5-min Apgar score <7
Mor et al, 202032 94·44 0·884 Stillbirth, induction of labour, 5-min 
Apgar score <7
None Gestational hypertension, gestational diabetes, vaginal 
delivery, instrumental delivery, caesarean section, 
umbilical artery pH <7·1, NICU admission
Pariente et al, 
202034
94·44 0·884 None Postpartum depression (EPDS score) Gestational hypertension, pre-eclampsia, maternal 
suicidal ideations (EPDS question 10 positive)
Philip et al, 202035 90·74 0·924 None Very low birthweight (<1500 g) Extremely low birthweight (<1000 g)
Silverman et al, 
202036
72·69 0·838 None Postnatal depression (EPDS score) None
Stowe et al, 202137 79·63 0·925 None None Stillbirths
Sun et al, 202038 81·02 0·573 No statistical analysis done No statistical analysis done No statistical analysis done
Suzuki et al, 202039 47·22 0·957 Maternal depression (Whooley questions) None None
Werner et al, 202040 72·69 0·838 No statistical analysis done No statistical analysis done No statistical analysis done
Wu et al, 202041 77·31 0·485 Postnatal depression (EPDS score), 
maternal anxiety (EPDS-3A score)
None None
Xie et al, 202143 81·94 0·485 Maternal depression, maternal anxiety 
(SCL-90-R score)
None None
Zanardo et al, 
202042
93·52 0·991 Postnatal depression (EPDS score) None Caesarean section
IDAS-II=Inventory of Depression and Anxiety SymptomS, Expanded Form. BAI=Beck Anxiety Inventory. NICU=neonatal intensive care unit. EDPS=Edinburgh Postnatal Depression Scale. NuPDQ=Revised Prenatal 
Distress Questionnaire. SCL-90-R=Symptom Checklist 90 Revised.
Table 2: Summary of findings of included studies 
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Studies Pandemic Pre-pandemic Odds ratio or mean 
difference*
p value I²
Events Pregnancies Events Pregnancies
Maternal and perinatal death
Stillbirth 12 1099 168 295 1325 198 993 1·28 (1·07–1·54) 0·0082 63%
HICs only 8 625 150 404 640 165 118 1·38 (0·94–2·02) 0·099 52%
LMICs only 4 474 17 891 685 33 875 1·29 (1·06–1·58) 0·012 64%
Neonatal death 3 62 13 214 120 22 570 1·01 (0·38–2·67) 0·98 85%
HICs only 1 5 2538 6 1262 0·41 (0·13–1·36) 0·14 NA
LMICs only 2 57 10 676 114 21 308 1·37 (0·42–4·46) 0·59 90%
Maternal death 2 530 1 237 018 698 2 224 859 1·37 (1·22–1·53) <0·0001 0%
HICs only 0 NA NA NA NA NA NA NA
LMICs only 2 530 1 237 018 698 2 224 859 1·37 (1·22–1·53) <0·0001 0%
Maternal morbidity and complications
Gestational diabetes 6 697 6946 954 10 137 1·01 (0·86–1·19) 0·85 45%
HICs only 5 667 6675 920 9826 1·02 (0·85–1·22) 0·86 56%
LMICs only 1 30 271 34 311 1·01 (0·60–1·71) 0·95 NA
Hypertensive disorders of 
pregnancy
6 293 6946 434 10 137 1·16 (0·75–1·79) 0·50 81%
HICs only 5 279 6675 431 9826 0·99 (0·67–1·46) 0·95 77%
LMICs only 1 14 271 3 311 5·59 (1·59–19·7) 0·0073 NA
EPDS score 3 NA 2330 NA 6517 0·42 (0·02–0·81) 0·038 79%
HICs only 1 NA 91 NA 101 2·16 (0·92–3·40) 0·0006 NA
LMICs only 2 NA 2239 NA 6416 0·22 (0·21–0·23) <0·0001 0%
Early pregnancy outcomes
Surgical treatment of ectopic 
pregnancy
3 27 37 73 272 5·81 (2·16–15·6) 0·0005 26%
HICs only 3 27 37 73 272 5·81 (2·16–15·6) 0·0005 26%
LMICs only 0 NA NA NA NA NA NA NA
Delivery outcomes
Spontaneous vaginal delivery 11 17 305 26 494 27 011 40 639 0·98 (0·93–1·02) 0·25 25%
HICs only 6 9675 14 632 11 288 16 362 0·99 (0·94–1·05) 0·80 4%
LMICs only 5 7630 11 862 15 723 24 277 0·96 (0·90–1·04) 0·33 37%
Caesarean section 17 15 304 48 550 20 656 67 442 1·03 (0·99–1·07) 0·14 46%
HICs only 11 10 091 33 161 10 824 36 956 1·01 (0·97–1·04) 0·76 10%
LMICs only 6 5213 15 389 9832 30 486 1·07 (0·99–1·16) 0·071 55%
Induction of labour 7 4860 16 459 5208 24 592 1·15 (0·81–1·64) 0·43 98%
HICs only 6 2578 9294 2950 11 403 1·03 (0·90–1·19) 0·64 76%
LMICs only 1 2282 7165 2258 13 189 2·26 (2·12–2·42) <0·0001 NA
Instrumental delivery 7 1045 16 287 1492 27 066 1·06 (0·97–1·15) 0·22 0%
HICs only 5 728 8168 740 10 300 1·07 (0·95–1·20) 0·88 0%
LMICs only 2 317 8119 752 16 766 1·02 (0·82–1·26) 0·25 0%
Preterm birth before 37 weeks’ 
gestation
15 13 466 170 640 49 596 656 423 0·94 (0·87–1·02) 0·13 75%
HICs only 12 11 600 159 987 46 149 635 118 0·91 (0·84–0·99) 0·035 63%
LMICs only 3 1866 10 653 3447 21 305 1·05 (0·81–1·35) 0·73 88%
Preterm birth before 34 weeks’ 
gestation
4 141 7039 210 9872 0·76 (0·42–1·36) 0·35 85%
HICs only 4 141 7039 210 9872 0·76 (0·42–1·36) 0·35 85%
LMICs only 0 NA NA NA NA NA NA NA
Preterm birth before 32 weeks’ 
gestation
6 2297 152 422 6679 627 344 0·95 (0·64–1·39) 0·77 90%
HICs only 5 2198 148 974 6409 619 269 0·96 (0·61–1·52) 0·87 86%
LMICs only 1 99 3448 270 8075 0·85 (0·68–1·08) 0·18 NA
(Table 3 continues on next page)
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table 3, appendix p 45). The substantial statistical 
heterogeneity (table 3) was explained by neither WHO 
Healthcare Efficiency Index quartile nor GRSI score 
(appendix p 39).
Quantitative synthesis was possible for gestational 
diabetes (OR 1·01 [95% CI 0·86–1·19]; I²=45%)4,15,19,31,32,34 
and hypertensive disorders of pregnancy (1·16 
[0·75–1·79]; I²=81%),4,15,19,31,32,34 which were not significantly 
different during the pandemic compared with before the 
pandemic (table 3, appendix p 48). The statistical 
heterogeneity in the meta-analysis of hypertensive 
disorders of pregnancy was partly explained by WHO 
Healthcare Efficiency Index quartile (p=0·023) but not 
GRSI score (p=0·89; appendix p 39).
Two studies19,30 reported on post-partum haemorrhage. 
Meta-analysis (including 3098 pregnancies during and 
1978 before the pandemic) found no significant difference 
associated with the pandemic (OR 1·02 [95% CI 
0·87–1·19]; I²=0%; table 3, appendix p 48).
11 studies reported on measures of maternal mental 
health.15,18,22,29,34,36,39,41–44 Assessment tools included the 
Generalised Anxiety and Depression Scale, EPDS, 
Generalised Anxiety Disorder 7 questionnaire, Inventory 
of Depression and Anxiety Symptoms (Expanded Form), 
Symptom Checklist 90 Revised, and Patient Health 
Questionnaire 9. Four studies18,36,41,42 gave mean EPDS 
scores (on a scale of 0–30). One study violated the 
normality assumption and was excluded from quantitative 
synthesis.36 For the remaining three studies, the pooled 
mean difference was 0·42 (95% CI 0·02–0·81; I²=79%; 
table 3, appendix p 49). There was significant statistical 
heterogeneity, not explained by either the WHO 
Healthcare Efficiency Index quartile (p=0·62) or GRSI 
score (p=0·057; appendix p 39). When subdivided 
according to country income status, there was a 
statistically significant increase in mean EPDS score in 
LMICs (0·22 [0·21 to 0·23]). Of the 11 studies reporting 
on maternal mental health, seven reported a statistically 
significant increase in postnatal depression, maternal 
anxiety, or both.
Three studies12,40,48 reported on the surgical management 
of ectopic pregnancy. Meta-analytical summary of three 
studies found increased odds for surgical treatment of 
ectopic pregnancy during the pandemic (OR 5·81 
Studies Pandemic Pre-pandemic Odds ratio or mean 
difference*
p value I²
Events Pregnancies Events Pregnancies
(Continued from previous page)
Preterm birth before 28 weeks’ 
gestation
3 605 135 606 2603 586 189 0·84 (0·46–1·53) 0·56 57%
HICs only 3 605 135 606 2603 586 189 0·84 (0·46–1·53) 0·56 86%
LMICs only 0 NA NA NA NA NA NA NA
Iatrogenic preterm birth, any week 2 208 4204 358 6818 0·92 (0·77–1·10) 0·38 0%
HICs only 2 208 4204 358 6818 0·92 (0·77–1·10) 0·38 0%
LMICs only 0 NA NA NA NA NA NA NA
Spontaneous preterm birth, 
any week
2 192 4204 374 6818 0·81 (0·67–0·97) 0·020 0%
HICs only 2 192 4204 374 6818 0·81 (0·67–0·97) 0·020 0%
LMICs only 0 NA NA NA NA NA NA NA
Postpartum haemorrhage 2 603 3098 318 1978 1·02 (0·87–1·19) 0·82 0%
HICs only 2 603 3098 318 1978 1·02 (0·87–1·19) 0·82 0%
LMICs only 0 NA NA NA NA NA NA NA
Neonatal outcomes
5-min Apgar score <7 4 35 5701 45 9081 1·15 (0·62–2·15) 0·95 44%
HICs only 4 35 5701 45 9081 1·15 (0·62–2·15) 0·95 44%
LMICs only 0 NA NA NA NA NA NA NA
Birthweight <2500 g 3 919 9743 1510 14 492 0·99 (0·90–1·08) 0·75 0%
HICs only 1 144 2538 78 1262 0·91 (0·69–1·21) 0·53 NA
LMICs only 2 775 7205 1432 13 230 0·99 (0·91–1·09) 0·90 0%
NICU admission 7 446 8072 1604 37 557 0·90 (0·80–1·01) 0·084 0%
HICs only 6 413 7801 1555 37 246 0·91 (0·80–1·03) 0·14 0%
LMICs only 1 33 271 49 311 0·74 (0·46–1·19) 0·21 NA
Data are n or point estimate (95% CI). HICs=high-income countries. LMICs=low-income and middle-income countries. NA=not applicable. EPDS=Edinburgh Postnatal 
Depression Scale. NICU=neonatal intensive care unit. *Random-effects estimates calculated by Mantel-Haenszel method for during versus before pandemic; all values are 
odds ratios, except the estimate for EPDS scores (mean difference).
Table 3: Results of the quantitative synthesis
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Kumari et al, 202025
Lumbreras-Marquez et al, 202027
Overall total
Heterogeneity: τ2=0; χ2=0·06, df=1 (p=0·81); I2=0%




















De Curtis et al, 202049
Dell'Utri et al, 202012
Handley et al, 202116
Justman et al, 202019 
McDonnell et al, 202030
Meyer et al, 202031
Mor et al, 202032
Stowe et al, 202137
Subgroup total
Heterogeneity: τ2=0·1200; χ2=14·71, df=7 (p=0·04); I2=52%
LMIC subgroup
Caniglia et al, 202047
Kc et al, 202021
Kumar et al, 202124
Kumari et al, 202025
Subgroup total
Heterogeneity: τ2=0·0272; χ2=8·42, df=3 (p=0·04); I2=64%
Overall total
Heterogeneity: τ2=0·0445; χ2=29·48, df=11 (p<0·01); I2=63%
































































































Werner et al, 202040
Casadio et al, 202048 
Dell'Utri et al, 202012
Overall total
Heterogeneity: τ2=0·1980; χ2=2·70, df=2 (p=0·26); I2=26%




























Berghella et al, 202033
De Curtis et al, 202049
Greene et al, 202014
Handley et al, 202116
Hedermann et al, 202117  
Justman et al, 202019   
Kasuga et al, 202020
Khalil et al, 20204
Main et al, 202028  
McDonnell et al, 202030  
Meyer et al, 202031
Mor et al, 202032
Subgroup total
Heterogeneity: τ2=0·0104; χ2=29·92, df=11 (p<0·01); I2=63%
LMIC subgroup
Caniglia et al, 202047
Kc et al, 202021 
Sun et al, 202038
Subgroup total
Heterogeneity: τ2=0·0339; χ2=16·7, df=2 (p<0·01); I2=88%
Overall total
Heterogeneity: τ2=0·0120; χ2=55·25, df=14 (p<0·01); I2=75%














































































































0·1 0·5 1·0 2·0 10·0
0·1 0·5 1·0 2·0 10·0
0·2 0·5 1·0 2·0 5·0
Figure 2: Forest plot of 
pooled ORs for maternal 
death (A), stillbirth (B), 
surgical management of 
ectopic pregnancy (C), and 
preterm birth before 
37 weeks’ gestation (D)
ORs are random-effects 





NA=not applicable. OR=odds 
ratio. *All studies investigating 
this outcome fell into a single 
subgroup (either LMIC or HIC); 
therefore, the subgroup totals 
are the same as the overall 
totals.
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[95% CI 2·16–15·6]; I²=26%; table 3, figure 2C), most of 
which were due to ruptured ectopic pregnancy.
On the basis of 11 studies,14,15,18,21,26,30–33,38,46 there was no 
significant change in the rate of spontaneous vaginal 
delivery (OR 0·98 [95% CI 0·93–1·02]; I²=25%; 
appendix p 51) during versus before the pandemic. 
17 studies,6,14,15,18,19,21,25,26,30–33,38,42,45,46,49 including 48 550 preg -
nancies during and 67 442 before the pandemic, showed 
no significant change in caesarean section rate (1·03 
[0·99–1·07]; I²=46%; table 3, appendix p 52), with 
consistent findings when subdivided into HICs 
and LMICs. Additionally, on the basis of seven 
studies,14,18,19,21,30–32 rates of instrumental delivery did not 
differ during versus before the pandemic (1·06 
[0·97–1·15]; I²=0%; table 3, appendix p 53). The funnel 
plot asymmetry tests showed no significant publication 
bias in the included studies for vaginal birth (p=0·53) or 
caesarean section (p=0·61; appendix pp 64–65).
Seven studies,12,14,19,21,30–32 including 16 459 pregnancies 
during and 24 592 before the pandemic, showed no 
significant difference in the rate of induction of labour 
(OR 1·15 [95% CI 0·81–1·64]; I²=98%; table 3, appendix 
p 54). The very high statistical heterogeneity was explained 
by WHO Healthcare Efficiency Index scores, with 
countries in the fourth quartile having lower induction 
rates (estimate –0·783, p<0·0001) than countries in the 
second quartile (appendix p 39). The only LMIC study21 
included in the meta-analysis reported a significant 
increase in induction of labour (2·26 [2·12–2·42]).
There was a significant decrease in preterm birth 
in specific subgroups. Preterm birth was reported in 
18 articles4,5,14–17,19–21,26,28,30–33,38,47,49 with varying gestational age 
thresholds, and conflicting findings. Several large studies 
reported a local decrease in preterm birth, mostly in 
western European countries.5,31,33,47,49 One large study 
reported an increase in preterm birth in Nepal.21 Pooled 
analysis showed no overall effect for preterm birth before 
37 weeks’ gestation (OR 0·94 [95% CI 0·87–1·02]; I²=75%; 
15 studies; table 3, figure 2D). However, subgroup 
analysis of 12 studies (including 159 987 pregnancies 
during the pandemic and 635 118 pre-pandemic) 
suggested that there might be a significant decrease in 
HICs (0·91 [0·84–0·99]; I²=63%). There was no overall 
effect on preterm birth before 34 weeks’ gestation (0·76 
[0·42–1·36]; I²=85%; four studies), 32 weeks’ gestation 
(0·95 [0·64–1·39]; I²=90%; six studies) or 28 weeks’ 
gestation (0·84 [0·46–1·53]; I²=57%; three studies; table 3, 
appendix pp 55–57). In a meta-regression analysis for 
preterm birth before 37 weeks’ gestation, neither WHO 
Healthcare Efficiency Index quartile (p=0·97) nor GRSI 
scores (p=0·17) adequately explained the statistical 
heterogeneity (appendix p 39). The funnel plot asymmetry 
test showed no significant publication bias in the included 
studies for preterm birth before 37 weeks’ gestation 
(p=0·13; appendix p 66). Two studies reported on 
iatrogenic and spontaneous preterm birth before 
37 weeks’ gestation, both in HICs;16,33 meta-analysis 
showed a significant decrease in spontaneous preterm 
birth (0·81 [0·67–0·97]; I²=0%) but no difference in 
iatrogenic preterm birth (0·92 [0·77–1·10]; I²=0%; table 3, 
appendix pp 59–60).
One study35 reported on the incidence of very low 
(<1500 g) and extremely low (<1000 g) birthweight as 
a proxy for preterm birth. This study reported a 
73% reduction in very low birthweight infants, consistent 
with the reduction in preterm birth found in the meta-
analysis. Three studies reported on the incidence of 
birthweight of less than 2500 g21,30,38 and found no 
significant difference associated with the pandemic 
(OR 0·99 [95% CI 0·90–1·08]; I²=0%; table 3, appendix 
p 61).
Seven studies reported on neonatal intensive care unit 
admissions. Meta-analysis (including 8072 pregnancies 
during and 37 557 before the pandemic) found no overall 
difference in the rate of neonatal intensive care unit 
admissions (OR 0·90 [95% CI 0·80–1·01]; I²=0%; table 3, 
appendix p 62).4,14,15,19,23,31,32
There were no significant differences in other neonatal 
outcomes between pandemic and pre-pandemic cohorts 
(table 3). Justman and colleagues19 reported no difference 
in the proportion of pregnancies with shoulder dystocia 
(p=0·26) or umbilical arterial pH below 7·0 (p>0·99). 
Seven studies assessed 5-min Apgar scores 
(tables 1, 2).14,15,19,23,31,32,38 We excluded from the meta-
analysis the studies by Gu and colleagues15 (scores 
reported as mean rather than binary [<7 vs ≥7]), Kugelman 
and colleagues23 (no adverse events reported), and Sun 
and colleagues38 (no statistical analysis done). Meta-
analysis of the remaining four studies14,19,31,32 showed no 
change in the proportion of pregnancies with 5-min 
Apgar scores of less than 7 (OR 1·15 [95% CI 0·62–2·15]; 
I²=44%; table 3, appendix p 63). Li and colleagues26 found 
no significant change in the proportion of pregnancies in 
which neonatal asphyxia was recorded (p=0·12). Meyer 
and colleagues31 reported on a composite score for 
adverse neonatal outcomes and found no difference 
between pandemic and pre-pandemic cohorts (p=0·12).
Discussion
This systematic review summarises the available global 
data on the effects of the COVID-19 pandemic on 
maternal and perinatal outcomes. We found increased 
maternal mortality and stillbirth, maternal stress, and 
ruptured ectopic pregnancies during the pandemic 
compared with before the pandemic. Stillbirth might be 
particularly increased in LMIC settings. There was no 
overall difference in preterm birth, but analyses of HIC 
data only suggested that both preterm birth before 
37 weeks’ gestation and spontaneous preterm birth might 
be reduced. WHO Healthcare Efficiency Index explained 
some of the observed between-study heterogeneity, but 
GRSI scores did not. This finding suggests that the 
increased rate of adverse outcomes might be driven 
mainly by the inefficiency of health-care systems and 
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their inability to cope with the pandemic, rather than by 
the stringency of pandemic mitigation measures.
The strengths of this review include the comprehensive 
search not restricted by language, and the inclusion and 
synthesis of a broad range of literature. We used meta-
regression to adjust for between-study heterogeneity in 
important outcomes, and analysed HIC and LMIC 
settings separately to clarify the differential effects of the 
pandemic by country income.
The main limitations are the retrospective design 
of the included studies, as well as the heterogeneity of 
the study populations and the definitions and ways of 
measuring outcomes, thereby limiting the comparability 
of results. There were fewer studies from LMIC settings 
than from HIC settings, which is concerning because our 
analysis showed substantial variation in outcomes 
between high-income and low-income settings. With 
regard to stillbirth, only one study reported on antepartum 
and intrapartum stillbirth separately, limiting our ability 
to speculate on the probable mechanism of this change. 
Few studies reported both stillbirth and preterm birth in 
the same cohort, which would be necessary to ascertain 
whether the cost of a reduction in preterm birth was an 
increase in stillbirth. Finally, we could not exclude the risk 
of publication bias against studies reporting negative 
findings, although funnel plot asymmetry testing for 
such bias was negative.
Early evidence suggested that the pandemic period was 
marked by a substantial decrease in preterm birth. Our 
findings from HICs supported this decrease, whereas 
those from LMICs did not. The report of a significant 
reduction in very low birthweight birth in Ireland further 
supports the hypothesis that preterm birth in HICs was 
reduced during the pandemic.35 Although no significant 
overall difference in neonatal death was observed, the 
data suggested that neonatal death might be increased in 
LMICs and decreased in HICs, consistently with the 
observed trends in preterm birth, a leading cause of 
neonatal mortality. This reduction in HICs appears to be 
driven by a reduction in spontaneous preterm birth, and 
is, therefore, not likely to be explained by reduced 
iatrogenic delivery. It is more likely that changes in 
health-care delivery and population behaviours are 
contributing factors. If a decrease in preterm birth has 
been achieved without a corresponding increase in fetal 
loss in some regions, there are valuable lessons to be 
learned from understanding the mechanisms underlying 
this effect.
The observed increase in maternal death is based only 
on data from LMICs. However, our findings are 
particularly concerning because these areas already carry 
the majority of the global burden of maternal mortality. 
This finding is supported by national data from Kenya 
not yet formally published,50 and we call for further 
investigation of maternal mortality as a matter of 
urgency, particularly in LMIC settings. Data from the 
MBRRACE-UK rapid report show that; in the first wave 
of the pandemic (March–May, 2020), there were 
16 maternal deaths (ten associated with SARS-CoV-2) of 
an estimated 162 344 births, corresponding to a maternal 
mortality rate of 9·9 per 100 000,51 compared with a 
pre-pandemic rate of 9·7 per 100 000 in 2016–18.
One proposed explanation for the increase in adverse 
pregnancy outcomes is that such outcomes could be 
linked to reduced access to care. Although maternal 
anxiety was consistently shown to be increased during the 
pandemic, health-care providers around the world have 
reported reduced attendance for routine6,13,15,52–55 and 
unscheduled pregnancy care.6,12,13,15,19,56 This reduction could 
be driven by concern about the risk of acquiring COVID-19 
in health-care settings, governmental advice to stay at 
home, or reduced public transport and childcare access 
during lockdowns.13,52 In HICs, much of routine care was 
rapidly restructured and delivered remotely using diverse 
models, including telephone or video-based appointments. 
Although technology can provide a COVID-19-secure path 
to continuity of antenatal care, there remains inequality of 
access for people without regular access to high-speed 
internet or privacy in their living space.57,58 In LMICs, 
where remote consultations are less feasible, people might 
simply miss out on preventive antenatal care entirely.13,53 
In all settings, the impact is greatest on the most 
vulnerable individuals in the population: in Nepal, 
hospital deliveries decreased, most markedly among 
disadvantaged groups;21 and in the UK, 88% of pregnant 
women who died during the first wave of the pandemic 
were from black and minority ethnic groups.51
Reduced access to care is not the sole factor to consider 
in our continuing response to this global emergency. 
During its peak prevalence, maternity staff have been 
redeployed to support critical care and medical teams, 
reducing the staffing available for maternity care. 
Following the first wave in the UK, the Royal College of 
Obstetricians and Gynaecologists argued strongly for 
excluding maternity staff from redeploy ment wherever 
possible. We strongly recommend the prioritisation of 
safe staffing for maternity services throughout all phases 
of the pandemic response and in response to future 
health system shocks.
Wider societal changes are also echoed in observed 
changes in maternal health. Intimate-partner violence, 
already a leading cause of maternal death, has increased 
during the pandemic59 and has already been highlighted51 
as a contributor to increased maternal mortality. Women 
have been disproportionately more likely to both become 
unemployed60 and take on more childcare because of 
nursery and school closures. The resultant financial 
and time constraints are likely to have far-reaching 
consequences for mothers’ physical, emotional, and 
financial health during pregnancy and in the future.
Health-care providers planning for service delivery in 
the ongoing pandemic must consider how to establish 
robust antenatal care pathways that explicitly reach out to 
vulnerable individuals and communities. Public health 
Articles
www.thelancet.com/lancetgh   Vol 9   June 2021 e771
messaging must emphasise the importance of antenatal 
care, and provide avenues of support for those at risk 
of intimate-partner violence. National governments must 
consider how to support financially vulnerable and socially 
isolated individuals, considering that each intersecting 
vulnerability magnifies risk across all contexts.51,61,62
It is clear that pregnant individuals and babies have 
been subjected to harm during the pandemic, and the 
onus is on the academic community, health-care 
providers, and policy-makers to learn from it. Women’s 
health-care is often adversely affected in humanitarian 
disasters63 and our findings highlight the central 
importance of planning for robust maternity services in 
any emergency response.
There remain opportunities to be seized as well as 
challenges to be faced as we work to end the grip of the 
pandemic on our global community. Rapid restructuring 
of maternity care has shown that high-quality remote care 
can be facilitated, reductions in hospital stay can be 
achieved, and apparently intractable and entrenched 
problems can be transformed by the concerted application 
of funding, scientific enquiry, and political will. We can 
prioritise safe and accessible maternity care during the 
pandemic and the aftermath, while planning for a future 
of radically inclusive and equitable maternity care that will 
draw on the lessons of this pandemic to reduce preterm 
birth, stillbirth, and maternal mortality worldwide.
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